Review Summarizes Skin Findings of Common Viral Infections
This review article summarizes epidemiology, clinical presentation, diagnosis, management, and prevention of common and vaccine-preventable viral infections with dermatologic relevance, including COVID-19, mpox, measles, and rubella. The authors state that advances in antiviral therapies, immunomodulators, vaccination, and post-exposure prophylaxis have improved outcomes for several of these infections, and note that the expanding therapeutic landscape and evolving public health recommendations create a need for an updated evidence-based review for dermatologists. The review emphasizes that recognition of characteristic skin findings and current diagnostic approaches are relevant to early diagnosis and limiting disease transmission.
Most relevant for: Clinicians evaluating mucocutaneous manifestations of COVID-19, mpox, measles, or rubella.
Read the original at Journal of the American Academy of DermatologySummary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.
Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.
Specialties
More dermatology updates
- Growth impairment in epidermal differentiation disorders varies by genotypeSep 30, 2026
- Expert panel issues consensus guidance on pediatric oral minoxidilSep 30, 2026
- Review outlines updated classification and workup for psychodermatologic conditionsSep 26, 2026
- Pustular flare risk identified after stopping biologics in psoriasisSep 25, 2026
- Class I recall: VITRUVIAS THERAPEUTICS INC: Thyroid Tablets, USP, 1/2 Grain (30 mg), Each tablet contains: levothyroxine (T4Sep 23, 2026